Data as of 4:00pm ET
| -0.03 / -0.16%|
The 6 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 22.00, with a high estimate of 24.00 and a low estimate of 14.00. The median estimate represents a +19.11% increase from the last price of 18.47.
The current consensus among 8 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.